Journal article · 2025 · Open access

Bile acid signaling in MASLD: From pathogenesis to therapeutic applications

Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner

Hepatology · Published 19 September 2025 · DOI 10.1097/hep.0000000000001539

Open full textCite this paper

In brief

“Bile acid signaling in MASLD: From pathogenesis to therapeutic applications” is a 2025 journal article by Benedikt Simbrunner and 3 co-authors, published in Hepatology. OpenAlex counts 32 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Hepatology.

Citations
32
Most cited in
2026 (31)
Field-weighted impact
9.95
References
276
Authors
4

Abstract

The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) causes considerable global morbidity and mortality. Dysregulated lipid and glucose metabolism are central elements in the pathogenesis of MASLD by promoting hepatocellular stress, inflammation, and liver fibrosis that may culminate in the development of cirrhosis and liver cancer. Moreover, intestinal dysbiosis and bacterial translocation trigger hepatic and systemic inflammation, further contributing to the pathogenesis and progression of MASLD. Bile acid (BA) receptors regulate hepatic metabolism and gut integrity as central players in the pathophysiology of MASLD. Therapeutic strategies targeting these BA receptors along the gut-liver axis, either directly through agonists or indirectly via modulation of BA transport, are currently within the focus of clinical research. This review summarizes mechanistic aspects of BA signaling in MASLD, key evidence of experimental and clinical studies on BA receptor agonists, and provides an outlook for future opportunities and challenges on the road to the implementation of novel therapies targeting BA receptors and BA signaling in MASLD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Simbrunner, B., Paternostro, R., Reiberger, T., & Trauner, M. (2025). Bile acid signaling in MASLD: From pathogenesis to therapeutic applications. Hepatology. https://doi.org/10.1097/hep.0000000000001539

MLA 9

Simbrunner, Benedikt, et al. “Bile acid signaling in MASLD: From pathogenesis to therapeutic applications.” Hepatology, 2025. https://doi.org/10.1097/hep.0000000000001539.

Chicago

Simbrunner, Benedikt, Rafael Paternostro, Thomas Reiberger, and Michael Trauner. 2025. “Bile acid signaling in MASLD: From pathogenesis to therapeutic applications.” Hepatology. https://doi.org/10.1097/hep.0000000000001539.

Harvard

Simbrunner, B. et al. (2025) ‘Bile acid signaling in MASLD: From pathogenesis to therapeutic applications’, Hepatology. doi:10.1097/hep.0000000000001539.

IEEE

B. Simbrunner, R. Paternostro, T. Reiberger, and M. Trauner, “Bile acid signaling in MASLD: From pathogenesis to therapeutic applications,” Hepatology, 2025, doi: 10.1097/hep.0000000000001539.

BibTeX

@article{simbrunner2025bile,
  title     = {{Bile acid signaling in MASLD: From pathogenesis to therapeutic applications}},
  author    = {Simbrunner, Benedikt and Paternostro, Rafael and Reiberger, Thomas and Trauner, Michael},
  journal   = {Hepatology},
  year      = {2025},
  doi       = {10.1097/hep.0000000000001539},
  url       = {https://doi.org/10.1097/hep.0000000000001539}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment

  • non-alcoholic fatty liver disease
  • bile acid signaling
  • bile acid receptors
  • gut-liver axis
  • gut dysbiosis
  • bacterial translocation
  • liver fibrosis
  • liver cirrhosis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Simbrunner, B., Paternostro, R., Reiberger, T., & Trauner, M. (2025). Bile acid signaling in MASLD: From pathogenesis to therapeutic applications. Hepatology. https://doi.org/10.1097/hep.0000000000001539

How many times has this paper been cited?

32 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Hepatology: sign in and open the full text from this page.

Who wrote this paper?

Benedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, Michael Trauner.

What is the DOI of this paper?

10.1097/hep.0000000000001539, permanently at https://doi.org/10.1097/hep.0000000000001539. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.